IL-4 INDUCES CHEMOTAXIS OF BLOOD EOSINOPHILS FROM ATOPIC-DERMATITIS PATIENTS, BUT NOT FROM NORMAL INDIVIDUALS

被引:48
作者
DUBOIS, GR
BRUIJNZEELKOOMEN, CAFM
BRUIJNZEEL, PLB
机构
[1] TNO,DEPT PHARMACOL,MED BIOL LAB,2288 GJ RIJSWIJK,NETHERLANDS
[2] UNIV UTRECHT HOSP,DEPT DERMATOL ALLERGOL,UTRECHT,NETHERLANDS
[3] SWISS INST ALLERGY & ASTHMA RES,DAVOS,SWITZERLAND
关键词
ATOPIC DERMATITIS; CYTOKINES; EOSINOPHILS; MIGRATION; INTERLEUKIN; 4;
D O I
10.1111/1523-1747.ep12382362
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
T lymphocytes present in allergically inflamed tissue synthesize and secrete the cytokines interleukin (IL)-3, IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor (GM-CSF). IL-3, IL-5, and GM-CSF, but also IL-4, may act as a chemotaxin on eosinophils. In contrast to the former cytokines, IL-4 is only chemotactic for eosinophils from the peripheral blood of patients with atopic dermatitis and not for eosinophils from normal individuals. IL-4 has the same chemotactic potency as the other cytokines. The optimal chemotactic potency is reached at a concentration of 10 nM. In contrast, neutrophils do not respond chemotactically to IL-4. Checkerboard analysis, inhibition studies with monoclonal anti-IL-4 antibodies, and desensitization experiments indicated specific interaction of IL-4 with eosinophils. In eosinophils from normal individuals, IL-4 responsiveness could be induced by pretreatment of the cells with IL-5 and GM-CSF. In addition to the fact that IL-4 may be responsible for selective eosinophil transendothelial migration, IL-4 may exert an important modulatory mode of action on eosinophil migration and function within allergically inflamed tissue. Our findings suggest the presence of a functional IL-4R on eosinophils from atopic dermatitis patients.
引用
收藏
页码:843 / 846
页数:4
相关论文
共 23 条
[11]  
MOSSMAN TR, 1986, ADV IMMUNOL, V46, P111
[12]   FIBROBLAST CHEMOTAXIS INDUCTION BY HUMAN RECOMBINANT INTERLEUKIN-4 - IDENTIFICATION BY SYNTHETIC PEPTIDE ANALYSIS OF 2 CHEMOTACTIC DOMAINS RESIDING IN AMINO-ACID-SEQUENCES 70-88 AND 89-122 [J].
POSTLETHWAITE, AE ;
SEYER, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (06) :2147-2152
[13]   ECZEMATOUS REACTIONS IN ATOPIC PATIENTS CAUSED BY EPICUTANEOUS TESTING WITH INHALANT ALLERGENS [J].
REITAMO, S ;
VISA, K ;
KAHONEN, K ;
KAYHKO, K ;
STUBB, S ;
SALO, OP .
BRITISH JOURNAL OF DERMATOLOGY, 1986, 114 (03) :303-309
[14]   INTERLEUKIN-INDUCED INCREASE IN IA EXPRESSION BY NORMAL MOUSE B-CELLS [J].
ROEHM, NW ;
LIEBSON, HJ ;
ZLOTNIK, A ;
KAPPLER, J ;
MARRACK, P ;
CAMBIER, JC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (03) :679-694
[15]   DIFFERENTIAL REGULATION OF IGG1 AND IGE SYNTHESIS BY INTERLEUKIN-4 [J].
SNAPPER, CM ;
FINKELMAN, FD ;
PAUL, WE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (01) :183-196
[16]  
SPITS H, 1988, J IMMUNOL, V141, P29
[17]  
THORNHILL MH, 1991, J IMMUNOL, V146, P592
[18]   SKIN-DERIVED AEROALLERGEN-SPECIFIC T-CELL CLONES OF TH2 PHENOTYPE IN PATIENTS WITH ATOPIC-DERMATITIS [J].
VANREIJSEN, FC ;
BRUIJNZEELKOOMEN, CAFM ;
KALTHOFF, FS ;
MAGGI, E ;
ROMAGNANI, S ;
WESTLAND, JKT ;
MUDDE, GC .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 90 (02) :184-192
[19]   ATOPIC-DERMATITIS - CORRELATION OF PERIPHERAL-BLOOD T-CELL ACTIVATION, EOSINOPHILIA AND SERUM FACTORS WITH CLINICAL SEVERITY [J].
WALKER, C ;
KAGI, MK ;
INGOLD, P ;
BRAUN, P ;
BLASER, K ;
BRUIJNZEELKOOMEN, CAFM ;
WUTHRICH, B .
CLINICAL AND EXPERIMENTAL ALLERGY, 1993, 23 (02) :145-153
[20]  
WALKER C, 1991, J IMMUNOL, V146, P1829